Cite

HARVARD Citation

    Gupta, A. et al. (2019). Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma. Pediatric pulmonology. 54 (12), pp. 1957-1967. [Online]. 
  
Back to record